(Total Views: 415)
Posted On: 10/02/2019 7:15:35 PM
Post# of 154915
LNTH at a 25% discount is pretty cheap. They have a decent revenue, and in case of fallback they collect penalties, and go back to original price.
They have done their homework, buyout out a cash negative corp.
Again, the only reason, is to quietly and under the radar increase their market share of Leronlomab.
I, myself, was looking for a chance to get into PGNX. But with this new and LNTH drop, couldn't help myself but to buy that.
All IMO.
They have done their homework, buyout out a cash negative corp.
Again, the only reason, is to quietly and under the radar increase their market share of Leronlomab.
I, myself, was looking for a chance to get into PGNX. But with this new and LNTH drop, couldn't help myself but to buy that.
All IMO.
(0)
(0)
